Conference
PO-40 PRODIGE: a randomized placebo-controlled trial of long-term thromboprophylaxis using dalteparin low molecular weight heparin (LMWH) in patients with newly diagnosed malignant glioma: updated results
Authors
Perry J; Rogers L; Laperriere N; Julian J; Geerts W; Agnelli G; Malkin M; Sawaya R; Baker R; Finch T
Volume
120
Publisher
Elsevier
Publication Date
January 2007
DOI
10.1016/s0049-3848(07)70193-7
Conference proceedings
Thrombosis Research
ISSN
0049-3848